Obesity-related insulin resistance is associated with changes in adipose tissue release of leptin, adiponectin, and nonesterified fatty acids (NEFAs). We have previously described that persons originating from the Indian subcontinent (Asian Indians) manifest excessive insulin resistance even in the absence of obesity. Therefore, in this study, we tested the hypothesis that nondiabetic, insulin-resistant Asian Indians differ from less insulin-resistant Caucasians of similar age and body composition in adipose tissue production of leptin and adiponectin, and in suppression of plasma NEFA concentrations during hyperinsulinemia. Seventy-nine Asian Indian men were compared with 61 Caucasian men. Higher plasma NEFAs and leptin in Asian Indians (P < 0.0001 and P ‫؍‬ 0.003 for NEFAs and leptin, respectively) and lower plasma concentrations of adiponectin (P ‫؍‬ 0.009) were not explained by body fat content and distribution. Oral glucose tolerance test studies revealed that Caucasian men had greater suppression of plasma NEFAs than Asian Indian men. We conclude that plasma concentrations of the adipose tissue metabolites leptin and NEFAs are higher and that of adiponectin is lower in insulin-resistant Asian Indians compared with more insulinsensitive Caucasians. These differences may contribute to the excessive prevalence of type 2 diabetes and cardiovascular disease in nonobese Asian Indians. (J Clin Endocrinol Metab 89: 2750 -2755, 2004) 
I NSULIN RESISTANCE, MEASURED as decreased insu-
lin-mediated glucose disposal, is considered to play a major role in the pathogenesis of both type 2 diabetes (1-4) and cardiovascular disease (CVD) (5) (6) (7) (8) . A common factor contributing to insulin resistance is obesity, which may suppress insulin sensitivity in several ways. One of these is through excess lipolysis, i.e. through release of large amounts of nonesterified fatty acids (NEFAs) into the circulation. Resulting high levels of NEFA seemingly raise triglyceride concentrations in skeletal muscle, thereby suppressing glucose uptake (9, 10) . Obesity may impair insulin action in other ways as well, through release of abnormal amounts of various other products from adipose tissue, notably, cytokines, leptin, and adiponectin (11, 12) . Obese persons often exhibit high plasma levels of high-sensitive C-reactive protein (CRP), which is one manifestation of high levels of circulating cytokines (13, 14) . Moreover, obesity is accompanied by high plasma levels of leptin and a low level of adiponectin, both of which suppress insulin action.
Insulin resistance and its associated excessive risk for both diabetes and CVD also may occur in absence of obesity. One example of this phenomenon may occur in populations originating in South Asia, i.e. Asian Indians. When individuals from these populations undergo urbanization or migration they manifest a high prevalence of premature type 2 diabetes (15) (16) (17) and CVD (18 -22) at body weights much lower than typically found in Caucasians with these conditions. We and other investigators have shown high frequency of insulin resistance (23) (24) (25) , even in the presence of a relative low body mass index (BMI), when compared with individuals of European descent. Although Asian Indians are known to be prone to upper body obesity, which is commonly associated with insulin resistance, we have observed that insulin resistance in Asian Indians is commonly present even in the absence of excessive body fat content or abdominal obesity (23) . Moreover, we have further reported that such nonobese Asian Indians typically exhibit high levels of CRP, suggestive of a proinflammatory state. Because obese persons commonly have high CRP levels, it is possible that adipose tissue metabolism is abnormal in persons with primary insulin resistance. However, at present, it is not known whether nonobese Asian Indians have features seen in obese Caucasians, namely, high levels of plasma NEFA and leptin or low levels of adiponectin. If they do, such findings would point to abnormalities of adipose tissue as contributors to insulin resistance in this population. In other words, in insulin-resistant Asian Indians, an abnormal function of adipose tissue could exist independently of body fat content, which could predispose them to type 2 diabetes and CVD.
The hypothesis of this study was that healthy nondiabetic, insulin-resistant men of Asian Indian origin will have higher plasma levels of NEFA and leptin and lower levels of adiponectin than will less insulin-resistant Caucasian men of similar age and body composition who are less insulin resistant. To test this hypothesis, we designed a cross-sectional study that compared parameters of body composition, insulin resistance, and plasma levels of NEFAs, leptin, and adiponectin in two groups of young, nondiabetic volunteers of Caucasian and Asian Indian ethnicity.
Subjects and Methods Subjects
Subjects were recruited through public advertisement and were screened for hematological and blood chemistry abnormalities. The study was approved by the Institutional Review Board of the University of Texas Southwestern Medical Center at Dallas. All subjects signed a written informed consent. Subjects with diabetes mellitus and other endocrine disorders, coronary heart disease, and liver function test abnormalities, and those receiving any form of therapies, were excluded from the study. At the time of enrollment, each volunteer was administered a health history questionnaire. The questionnaire did not include a report on length of stay in the United States. Height, weight, and blood pressure measurements were taken on all of the subjects.
Oral glucose tolerance test (OGTT)
After 12 h of fasting, subjects had an iv catheter placed in a forearm vein to collect blood. A solution containing 75 g glucose was administered orally to the subjects (Tru-Glu 100; Fisher Scientific, Pittsburgh, PA). Blood was collected at times Ϫ30, Ϫ15, 0, 30, 60, 90, 120, 150, and 180 min for measurement of glucose, insulin, leptin, adiponectin, and NEFA concentrations. Plasma was separated rapidly from the remaining blood by centrifugation at 4 C and stored immediately at Ϫ80 C. Results at times Ϫ30, Ϫ15, and 0 min were averaged as baseline measurements for analysis.
Biochemical analyses
Plasma glucose concentration was assayed using a glucose oxidase method. Plasma insulin and leptin were measured by RIA at Linco Research, Inc. (St. Louis, MO). Plasma adiponectin was measured by ELISA at Linco Research. The plasma concentrations of free fatty acids were measured by enzymatic colorimetric assay (Roche Diagnostics, Mannheim, Germany).
Anthropometry
Anthropometric measurements were taken on all of the subjects. Height and weight were measured by standard procedures. Waist circumference was measured at the umbilical level. The average of two measurements was used for analysis. Skinfold thickness was measured at nine different anatomical sites (subscapular diagonal and vertical, chest, midaxillary, abdominal horizontal and vertical, suprailiac diagonal and vertical, triceps, biceps, thigh, and calf) using a Lange skinfold caliper (Cambridge Scientific Instruments, Inc., Cambridge, MD), as previously reported (23) . Body density was calculated from measurements of body volume determined by hydrostatic weighing with adjustment for residual volume measured by helium dilution during the underwater weighing. Percentage of body fat was calculated using the Siri equation (26) assuming a fat-free density of 1.10 g/cc for men and 1.097 g/cc for women.
Statistical analysis and calculations
Area under the curve (AUC) during OGTT was calculated for glucose and insulin using the trapezoidal rule. Homeostasis model assessment of insulin resistance was calculated from insulin and glucose concentrations using the following equation: insulin (milliunits per milliliter) ϫ [glucose (nanomoles per liter)/22.5] (27). Mann-Whitney U test was used to compare the Asian Indian and Caucasian groups. For skewed variables (leptin, adiponectin, AUC insulin , and AUC NEFA ), the data were log transformed before analysis. Adjusted means were derived and compared using analysis of covariance models. Spearman correlation coefficients were used to assess associations between continuous variables. Statistical analysis was performed using SAS version 8.2 (SAS Institute, Cary, NC).
Results
The general characteristics of Asian Indian men are compared with those of the Caucasian men in Table 1 . Seventynine Asian Indians and 61 Caucasians participated in this study. We have no information on length of stay in the United States of either study group. The two groups were of similar age, and all were healthy without any acute or chronic illness. Asian Indians had lower mean BMI than Caucasians (24 Ϯ 3 and 26 Ϯ 4 kg/m 2 , respectively; P ϭ 0.004). Systolic but not diastolic blood pressure was higher in Caucasians. Plasma lipid levels were similar in the two groups. As shown in Table 2 , Asian Indians had less total body fat mass. However, body fat content, expressed as percentage of total body weight, was similar to that of the Caucasians. Truncal skinfold thickness was greater in Asian Indians, indicating a tendency to store body fat in truncal sc adipose tissue. However, the average waist circumference was lower in Asian Indians. No differences were noted for hip circumference or peripheral skinfold thickness.
Fasting levels of plasma glucose were not different between the two groups (95 Ϯ 9 and 94 Ϯ 7 mg/dl in Asian Indians and Caucasians, respectively; P ϭ 0.16), but fasting plasma insulin was significantly higher in Asian Indians (16 Ϯ 12 vs. 13 Ϯ 6 U/ml; P ϭ 0.01), suggesting greater insulin resistance. This findings were confirmed using homeostasis model assessment of insulin resistance (4.0 Ϯ 3.5 and 2.9 Ϯ 1.6 for Asian Indians and Caucasians, respectively; P ϭ 0.018). As shown in Fig. 1 , fasting plasma NEFA levels were significantly higher in Asian Indians. Asian Indians also had significantly higher plasma leptin concentrations and lower plasma adiponectin concentrations compared with Caucasians (Fig. 1 ). These differences remained highly significant even after adjustment for total body fat content, waist, and truncal skinfold thickness; adjusted P values were 0.001, Ͻ0.0001, and 0.02, for group differences in fasting plasma NEFA, leptin and adiponectin, respectively. Results are expressed as mean Ϯ SD, unless otherwise specified. P values were determined using the Mann-Whitney U test for comparison of means. SI conversion for cholesterol is 0.02586 mmol/liter, and for triglycerides is 0.0113 mmol/liter. Results are expressed as mean Ϯ SD, unless otherwise specified. P values were determined using the Mann-Whitney U test for comparison of means. Table 3 shows the relationships between body fat and parameters of fat distribution with plasma concentrations of NEFA, leptin, adiponectin, and AUC insulin . In both groups, increasing generalized (total body fat) and central adiposity (waist and truncal skinfold thickness) was accompanied by higher levels of leptin, AUC insulin , and AUC NEFA . Increasing generalized and central adiposity was also associated with reduced plasma concentrations of adiponectin. Some apparent differences in correlations between the two ethnic groups could be related to small variability of studied parameters within each group. Table 4 is a summary of Spearman correlation coefficients between metabolic variables including leptin, adiponectin, AUC NEFA , and AUC insulin . Small variability of studied parameters may account for apparent differences in r values between the two study groups.
Asian Indians had higher plasma glucose concentrations and higher plasma insulin concentrations during the OGTT (Fig. 2) . Plasma concentrations of NEFAs were significantly higher at baseline in the Asian Indians (Fig. 1) , and they remained significantly higher throughout the duration of the OGTT (Fig. 2) . Despite higher insulin levels, Asian Indian men had less suppression of plasma NEFA concentrations for the last 20 min of the OGTT-induced hyperinsulinemia compared with the Caucasian group (Fig. 2) . Percentage of suppression of plasma NEFA concentrations at time 120 min of OGTT was 90 Ϯ 14% for the Asian Indians and 94 Ϯ 14% for the Caucasians (P ϭ 0.003). These differences in NEFA levels during the OGTT persisted even after statistical adjustments for total body fat content and central adiposity parameters (adjusted value of P ϭ 0.0005).
Discussion
There are three salient findings in this study. First, plasma concentrations of NEFAs are higher and insulin-mediated plasma NEFA suppression is impaired in Asian Indian men compared with Caucasians; second, plasma leptin concentrations are higher in Asian Indian men compared with Caucasians; and third, plasma adiponectin concentrations are lower in Asian Indian men compared with Caucasians. These differences are found to be unrelated to body fat content or distribution.
FIG. 1. Fasting plasma concentrations of NEFA, leptin, and adiponectin in Asian
Indians and Caucasians. The results are reported as median, 25th to 75th percentiles, and 5th to 95th percentiles for the Asian Indians (o) and Caucasians (Ⅺ). P value was determined with independentsamples t test. High levels of plasma NEFA concentrations have been proposed to be an important link between adipose tissue and defective insulin-mediated glucose disposal primarily occurring in the skeletal muscle cells. Several mechanisms of how elevated NEFAs decrease insulin sensitivity have been proposed; these include a modification of the glucose-fatty acid cycle of Randle et al. (28) and/or inhibition of proximal insulin-signaling pathways (29) . Adipose tissue is the only major tissue in which triacylglycerol clearance from lipoproteins and fatty acid trapping are specifically up-regulated during hyperinsulinemia (30, 31) . Furthermore, adipose tissue is the only site of release of NEFAs. The finding that, despite relative hyperinsulinemia, Asian Indians have higher fasting plasma NEFA concentrations points to a higher release of NEFAs from the adipose tissue of Asian Indians. In addition, during the hyperinsulinemia induced by oral glucose administration, Asian Indians failed to manifest complete suppression of plasma NEFAs. Reasons for defective insulin action in the adipose tissue are not evident from our study. Nonetheless, a concomitant high concentration of plasma leptin and a low level of plasma adiponectin further point to an abnormality in adipose tissue metabolism of Asian Indians.
Leptin is produced in adipocytes. Increasing body fat content, particularly increasing sc abdominal fat content, is often accompanied by higher plasma leptin concentrations (32) (33) (34) . In our study, plasma leptin concentrations were strongly correlated with total body fat content and measures of truncal fat distribution (Table 3 ). In the Asian Indians of this study, there was no increase in overall body fat content. However, there was an increased thickness of truncal skinfolds. When the comparison of the study groups was done with statistical adjustment for truncal skinfold thickness, Asian Indians still had significantly higher plasma leptin concentrations than Caucasians (Fig. 1) . This supports excessive leptin production from adipocytes of Asian Indians regardless of the degree of overall obesity or abdominal/ truncal obesity. High plasma leptin concentrations in obesity seem to be accompanied by leptin resistance (35) and may be involved in the pathogenesis of obesity-related insulin resistance through peripheral effects of leptin on fatty acid metabolism. Leptin promotes fatty acid oxidation in cells (36) . Decreased leptin action may predispose to triglycerides accumulation in skeletal muscle cells, a condition associated with impaired insulin-mediated glucose use (9) . However, the mechanistic link between insulin resistance and hyper- . P values were determined with independent-samples t test after log transformation. SI conversion for glucose is 0.0555 mmol/liter, and for insulin is 6.945 pmol/liter. leptinemia is not completely elucidated. Because prolonged experimental hyperinsulinemia can induce an increase in plasma leptin concentration (36) , it is also possible that insulin resistance and hyperinsulinemia contribute to hyperleptinemia. In our study, plasma leptin concentrations were significantly correlated with AUC insulin during OGTT, both in Asian Indians and Caucasians. In the Asian Indians, insulin levels were clearly elevated and thus might have contributed to the higher plasma leptin concentrations of this ethnic group.
Adiponectin is another product of adipocytes. Lower plasma levels of adiponectin have been reported in obesityrelated insulin resistance, and there is an inverse relationship between plasma concentrations of adiponectin and leptin (37) (38) (39) (40) . The role of adiponectin on the pathogenesis of insulin resistance is at this time incompletely understood. In this study, we could confirm for the Asian Indians the relationships between adiponectin and parameters of obesity, fat distribution, and insulin resistance previously reported in other ethnic groups. In both of our study groups, increasing truncal skinfold thickness was the strongest correlate of decreased plasma adiponectin concentrations (Table 3) . Because Asian Indians had higher truncal skinfold thickness, we evaluated the differences between Asian Indians and Caucasians, after statistical adjustment for body fat content, waist circumference, and truncal skinfold thickness. Similar to the findings for leptin, this analysis shows that Asian Indians have significantly higher plasma adiponectin concentrations independently of obesity and fat distribution (Fig. 1 ). Imaging studies with direct measurement of visceral adipose tissue and sc abdominal adipose tissue may be required to confirm our findings using anthropometric measurements of fat distribution.
Taken together, the findings of our study point to a defect in adipose tissue metabolism of Asian Indians, which occurs independently of obesity or abdominal fat distribution. These abnormalities of adipose tissue metabolism are concomitant with insulin resistance. Therefore, it is not possible to determine causal sequence, i.e. whether a primary defect in the insulin signaling pathway is responsible for abnormal metabolism in adipose tissue, or vice versa. If the former, a vicious cycle might be established in which primary insulin resistance engenders abnormal adipose tissue metabolism, which in turn enhances insulin resistance in muscle by abnormal release of various products including NEFA, inflammatory cytokines, leptin, and adiponectin. In any case, increased plasma NEFA and leptin concentrations, and decreased plasma adiponectin concentrations in Asian Indians appear to be part of a complex clustering of metabolic abnormalities that includes insulin resistance that is characteristic of this ethnic group, even in absence of obesity. Nonetheless, once some degree of obesity intervenes, these abnormalities likely will be accentuated. Thus, regardless of the precise molecular underpinning of this metabolic pattern, its presence seemingly represents a genetic susceptibility to insulin resistance that, when combined with increasing obesity, can account for the increasing prevalence of type 2 diabetes and CVD in this ethnic group.
